CS181779B2 - Process for preparing 11 beta-fluor-4-androsten-3-ones containing oxygen group in position 17 - Google Patents

Process for preparing 11 beta-fluor-4-androsten-3-ones containing oxygen group in position 17

Info

Publication number
CS181779B2
CS181779B2 CS7500001236A CS123675A CS181779B2 CS 181779 B2 CS181779 B2 CS 181779B2 CS 7500001236 A CS7500001236 A CS 7500001236A CS 123675 A CS123675 A CS 123675A CS 181779 B2 CS181779 B2 CS 181779B2
Authority
CS
Czechoslovakia
Prior art keywords
androsten
fluor
beta
preparing
containing oxygen
Prior art date
Application number
CS7500001236A
Other languages
Czech (cs)
English (en)
Inventor
Helmut Hofmeister
Henry Laurent
Rudolf Wiechert
Klaus Annen
Hermann Steinbeck
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CS181779B2 publication Critical patent/CS181779B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0029—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/005—3 membered carbocyclic rings in position 12
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CS7500001236A 1974-03-01 1975-02-25 Process for preparing 11 beta-fluor-4-androsten-3-ones containing oxygen group in position 17 CS181779B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2410443A DE2410443A1 (de) 1974-03-01 1974-03-01 11beta-fluor-androstene

Publications (1)

Publication Number Publication Date
CS181779B2 true CS181779B2 (en) 1978-03-31

Family

ID=5909131

Family Applications (1)

Application Number Title Priority Date Filing Date
CS7500001236A CS181779B2 (en) 1974-03-01 1975-02-25 Process for preparing 11 beta-fluor-4-androsten-3-ones containing oxygen group in position 17

Country Status (16)

Country Link
US (1) US3966713A (fr)
JP (1) JPS50121259A (fr)
BE (1) BE826139A (fr)
CA (1) CA1037024A (fr)
CS (1) CS181779B2 (fr)
DD (1) DD118623A5 (fr)
DE (1) DE2410443A1 (fr)
DK (1) DK137539C (fr)
ES (1) ES435204A1 (fr)
FR (1) FR2262528B1 (fr)
GB (1) GB1504410A (fr)
HU (1) HU170643B (fr)
IL (1) IL46712A0 (fr)
NL (1) NL7502445A (fr)
SE (1) SE7502239L (fr)
SU (1) SU656529A3 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
AU777770C (en) 1999-05-04 2005-11-10 Strakan International Limited Androgen glycosides and androgenic activity thereof
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
EP2265629B1 (fr) * 2008-03-05 2015-06-24 Evestra, Inc. Carbolactones de bisméthylène-17 et utilisations associées
WO2010068500A2 (fr) * 2008-11-25 2010-06-17 Evestra, Inc. Γ-lactones d'acide 3-(6,6-éthylène-17β-hydroxy-3-oxo-17α-prégna-4-ène-17α-yl)propionique progestatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3056807A (en) * 1961-10-09 1962-10-02 Upjohn Co Process for the preparation of fluorosteroids
US3875148A (en) * 1971-07-09 1975-04-01 Glaxo Lab Ltd 9{60 -unsubstituted-11{62 -bromo-19-norsteroids
US3767685A (en) * 1972-02-02 1973-10-23 Akzona Inc Novel 11beta-halo-steroids of the oestrane series

Also Published As

Publication number Publication date
HU170643B (fr) 1977-07-28
US3966713A (en) 1976-06-29
FR2262528A1 (fr) 1975-09-26
SE7502239L (fr) 1975-09-02
NL7502445A (nl) 1975-09-03
DD118623A5 (fr) 1976-03-12
DE2410443A1 (de) 1975-09-11
BE826139A (fr) 1975-08-28
ES435204A1 (es) 1976-12-16
DK137539B (da) 1978-03-20
SU656529A3 (ru) 1979-04-05
IL46712A0 (en) 1975-04-25
DK137539C (da) 1978-09-04
AU7855175A (en) 1976-08-26
DK78775A (fr) 1975-11-03
FR2262528B1 (fr) 1978-06-30
JPS50121259A (fr) 1975-09-23
GB1504410A (en) 1978-03-22
CA1037024A (fr) 1978-08-22

Similar Documents

Publication Publication Date Title
CS183829B2 (en) Process for preparing thienamycine
HU174074B (hu) Sposob poluchenija 4-polialkoksi-fenil-2-pirrolidona
HU171059B (hu) Sposob poluchenija piridazinil-benzimidazolov
HU173988B (hu) Sposob poluchenija 1-sul'fonil-benzimidazolov zamehhjonnykh v pozicii 5/6/
HU171231B (hu) Sposob poluchenija iodo-polivinilpirrolidona
CS187466B2 (en) Process for preparing 2-arylamino-2-imidazolines
YU37119B (en) Process for obtaining 4'-epi-6'-hydroxydaunomycin
YU45275A (en) Process for preparing basic alumonium oxycarbonate-hydrate
JPS51136600A (en) Process for preparing gammaaferric oxide*3*
CS189730B2 (en) Process for preparing o-cyanazodyes
CS191290B2 (en) Process for preparing aminoalkylphenyletheres
HU175380B (hu) Sposob poluchenija tiolkarbamatov
HU171837B (hu) Sposob poluchenija 14 al'fa-gidroksi-steroidov
CS193518B2 (en) Process for preparing moenomycine
IL44361A0 (en) Process for preparing 3-fluoro-cephalosporins
CS188259B2 (en) Process for preparing 2-anilinooxazoles
CS181779B2 (en) Process for preparing 11 beta-fluor-4-androsten-3-ones containing oxygen group in position 17
CS188984B2 (en) Process for preparing 3-fluorbenzodiazepines
GB1486844A (en) Process for preparing 7beta-acylamino-7alpha-alkoxy-cephalosporins
HU173847B (hu) Sposob poluchenija 6-metil-8 beta-izocianometil- ehrgolina
JPS5259095A (en) Process for preparing gammaaferric oxide*3*
JPS5259096A (en) Process for preparing gammaaferric oxide*3*
HU172658B (hu) Sposob poluchenija benzol-sul'fonil-karbamidov
HU172273B (hu) Sposob poluchenija 2-dejtero-3-ftor-dl-alanina
CS183813B2 (en) Process for preparing 6-aminopenicilic and 7-aminocephalosporic acid